<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="/prwebFeeds.xsl"?>
<rss version="2.0">
  <channel>
    <title>PRWeb.com Press Release Feed - PRWeb Press Release Account Feed</title>
    <link>http://www.prweb.com</link>
    <description>PRWeb.com Press Release Feed - Press Releases</description>
    <language>en</language>
    
    <managingEditor>xml@emediawire.com</managingEditor>
    <webMaster>xml@emediawire.com</webMaster>
    <ttl>30</ttl>

<item>
    <title>Pluromed, Inc. Signs Agreement with Boston Scientific </title>
    <link>http://www.prweb.com/releases/2009/10/prweb3011074.htm</link>
    <description>
        <![CDATA[  <P>Boston Scientific to distribute Pluromed&#039;s BackStop&#8482; device, a rapid phase transition gel used in the treatment of Kidney Stones. (PRWeb Oct 8, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/10/prweb3011074.htm">http://www.prweb.com/releases/2009/10/prweb3011074.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/10/prweb3011074.htm</guid>
</item>

<item>
    <title>Pluromed, Inc. Announces FDA Approval for BackStop&#8482; </title>
    <link>http://www.prweb.com/releases/2009/09/prweb2927324.htm</link>
    <description>
        <![CDATA[  <P>Pluromed, Inc. announced approval by the U.S. Food and Drug Administration (FDA) for  BackStop&#8482; (http://pluromed.com/products_top.htm), a device used in ureteroscopic kidney stone management procedures. BackStop was approved as a Class II device under the pre-market notification 510(k) process. (PRWeb Sep 23, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2009/09/prweb2927324.htm">http://www.prweb.com/releases/2009/09/prweb2927324.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2009/09/prweb2927324.htm</guid>
</item>

<item>
    <title>Pluromed, Inc. Awarded Massachusetts Life Sciences Center Accelerator Program Loan</title>
    <link>http://www.prweb.com/releases/medical_devices/investment/prweb2435054.htm</link>
    <description>
        <![CDATA[  <P>Pluromed, Inc., a medical device manufacturer revolutionizing the way bleeding is controlled during surgery, has announced that it has been awarded a $500,000 loan from The Massachusetts Life Sciences Center, a quasi-public agency tasked with implementing the State&#039;s $1 billion Life Sciences Initiative.  Pluromed is one of seven life sciences companies in Massachusetts, out of a total of eighty-eight applicants, to receive a share of the $3.4 million in loans from the Center&#039;s Accelerator Program. (PRWeb May 19, 2009)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/medical_devices/investment/prweb2435054.htm">http://www.prweb.com/releases/medical_devices/investment/prweb2435054.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/medical_devices/investment/prweb2435054.htm</guid>
</item>

<item>
    <title>Pluromed Receives Major International Surgery Award for its Innovative LeGoo Vascular Product Line</title>
    <link>http://www.prweb.com/releases/2008/10/prweb1446424.htm</link>
    <description>
        <![CDATA[  <P>Pluromed, Inc. received prestigious 2008 Award for the most important technological breakthrough in any area related to thoracic and cardiovascular surgery for its LeGoo product line. LeGoo is approved for human use in Europe and is already in clinical use in some of the leading clinical centers of France, Germany, The Netherlands, Spain and Switzerland. The market includes over 2,000,000 procedures a year in elder and diabetic patients with fragile arteries. Pluromed  is a private medical device company pioneering clampless vascular and cardiovascular surgery. (PRWeb Oct 9, 2008)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/10/prweb1446424.htm">http://www.prweb.com/releases/2008/10/prweb1446424.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2008/10/prweb1446424.htm</guid>
</item>

<item>
    <title>Medical Device Pioneer Pluromed Closes $4M Series B Financing</title>
    <link>http://www.prweb.com/releases/2008/07/prweb1116914.htm</link>
    <description>
        <![CDATA[  <P>Pluromed Inc (http://www.pluromed.com)., a private medical device company that is pioneering atraumatic temporary vascular occlusion, announced today that it closed a $4.0M Series B financing from private investors, including 7 current and former CEOs of U.S. medical device companies. The offering was oversubscribed. (PRWeb Jul 17, 2008)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2008/07/prweb1116914.htm">http://www.prweb.com/releases/2008/07/prweb1116914.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2008/07/prweb1116914.htm</guid>
</item>

<item>
    <title>Pluromed Recruits VP - Operations</title>
    <link>http://www.prweb.com/releases/2005/11/prweb314231.htm</link>
    <description>
        <![CDATA[  <P>Novel Medical Device Company Pluromed Inc. recruits strong industry Executive to drive the Company towards market clearance of its lead product. (PRWeb Nov 30, 2005)</P>
        <P>Read the full story at <a href="http://www.prweb.com/releases/2005/11/prweb314231.htm">http://www.prweb.com/releases/2005/11/prweb314231.htm</a></P>]]>
    </description>
    <guid isPermaLink="true">http://www.prweb.com/releases/2005/11/prweb314231.htm</guid>
</item>

</channel>
</rss>